Hello everyone nice to see you again We hope the long weekend was relaxing and fun Those extended breaks are enjoyable yes Now though the time has come to resume the usual routine of meetings and deadlines and whatnot And not surprisingly there is much to be done After all there is a reason it is called work How to cope Please join us for an invigorating cup of stimulation Our flavor this morning is Southern Pecan for those who care to dabble Meanwhile here are some tidbits Hope your day goes well and do stay in touch For the first time a new type of cancer treatment that is generating considerable excitement among physicians and investors has received regulatory approval The socalled checkpoint inhibitor from Ono Pharmaceutical and BristolMyers Squibb was approved in Japan And a study of  Medicare patients found testosterone therapy did not increase the risk of heart attacks contrary to several earlier studies The findings are a boost for proponents of testosterone therapy but still are unlikely to settle longstanding debate over testosterone safety